CRISPR/Cas9 has been widely used for the identification of potential therapeutic targets in cancer.

•

Several potential targets such as CD38, CXCR2, MASTL and RBX2 have been identified using CRISPR/Cas9.

•

CRISPR/Cas9 is able to specifically target mutant alleles of oncogenes such as EGFR and KRAS.

•

CRISPR/Cas9 delivery methods need to be improved before entering into clinic.

This will be a good technology that can be used to edit genes for therapeutic purposes.

Could be

Can be

Might be

....

However, it is up to scientists judging and valueing facts (not opinions, hope, ..)

Thanks

Björn